FTM
BECOME A MEMBER
() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: Funding

  • Home
  •  | 
  • Tag Archives: "Funding"

MedMen Enters Into Definitive Documentation for US$250 Million Investment From Gotham Green Partners and Closes Initial Funding Tranche

MedMen Enters Into Definitive Documentation for US$250 Million Investment From Gotham Green Partners and Closes Initial Funding Tranche
MedMen Enterprises Inc. (CSE:MMEN) (OTCQX:MMNFF) (FSE: A2JM6N) ("MedMen" or the "Company"), is pleased to announce that, further to its press release dated March 22, 2019, it has entered into definitive agreements in respect of a US$250,000,000 secured convertible credit facility (the "Facility") with Gotham Green Partners, an investor in the global cannabis industry.
Read more

Canada House Announces Further Details of Vegreville Acquisition and Second Tranche of Funding from Alumina Partners

Canada House Announces Further Details of Vegreville Acquisition and Second Tranche of Funding from Alumina Partners
Jan. 04, 2019 (GLOBE NEWSWIRE) -- Last month, Canada House Wellness Group Inc. (“Canada House” or the “Company”) was pleased to announce the acquisition through its wholly owned subsidiary Abba Medix Corp., of all the assets of an Alberta based cannabis production license applicant, including approximately 54 acres of property in the town of Vegreville, Alberta.
Read more

InMed Pharmaceuticals Receives Funding from the Government of Canada to Support Development of Novel Cannabinoid Biosynthesis Program

InMed Pharmaceuticals Receives Funding from the Government of Canada to Support Development of Novel Cannabinoid Biosynthesis Program
InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a cannabinoid-based biopharmaceutical company that leverages its proprietary platform technologies to develop novel therapeutics for the treatment of diseases with high unmet medical needs, is pleased to announce that it has signed a contribution agreement with the National Research Council Canada Industrial Research Assistance Program ("NRC IRAP") to receive funding of up to C$500,000 to support InMed's ongoing R&D efforts in cannabinoid biosynthesis.
Read more